Colorectal Cancer Diagnostics Market Growth Report | 2023-2028
[研究报告] 结直肠癌诊断市场规模预计将从 2022 年的 103.7468 亿美元增长到 2028 年的 169.9648 亿美元;预计 2023 年至 2028 年的复合年增长率为 8.7%。
结直肠癌诊断市场根据 模式、最终用户和地理位置进行细分。该报告提供了见解和深入的市场分析,强调了驱动因素、趋势、机会和各地区主要市场参与者的竞争格局分析等参数。它还包括对 COVID-19 疫情对各主要地区影响的分析。
市场洞察
新产品的推出推动结直肠
结直肠癌诊断市场的主要参与者生产各种设备,帮助减轻结直肠癌和其他相关适应症(如结肠息肉、克罗恩病、结肠炎和肠易激综合征)的负担。2022 年 7 月,美国消化健康 (USDH) 是一家顶级胃肠道 (GI) 诊所网络,该网络宣布将 AI 辅助结肠镜检查商业化,并安装美国最大的 Genious Intelligent GI 内窥镜模块。这些模块有望帮助医生实时识别难以检测且可能致癌的息肉。随着这款设备的推出,宾夕法尼亚州东南部、西南部和中部的患者现在可以使用功能增强的 AI 辅助结肠镜检查。2020 年 9 月,奥林巴斯公司宣布推出由人工智能 (AI) 驱动的尖端平台 ENDO-AID。该平台包括 ENDO-AID CADe 应用程序 (app),这是一种用于检测结肠不同状况的计算机辅助内窥镜方法。该款新型 AI 平台能够实时显示自动检测到的可疑病变,并与其 EVIS X1 配合使用。因此,频繁的开发和新产品的推出推动了结直肠癌诊断市场的增长。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
结直肠癌诊断市场:
Colorectal Cancer Diagnostics Market: Strategic Insights
Colorectal Cancer Diagnostics Market
-
CAGR (2022 - 2028)
8.7%
-
Market Size 2022
US$ 10.37 Billion
-
Market Size 2028
US$ 17 Billion
Market Dynamics
GROWTH DRIVERS
- 结直肠癌发病率不断上升
- 新产品发布
FUTURE TRENDS
- 结肠镜检查中的人工智能
OPPORTUNITIES
- 人们对结直肠癌的认识不断提高
Key Players
- Medtronic Plc
- Illumina Inc
- Clinical Genomics Technologies Pty Ltd
- EDP Biotech Corp
- Epigenomics AG
- F Hoffmann La Roche Ltd
- Quest Diagnostics Inc
- Novigenix SA
- Siemens Healthineers AG
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
检查方式(影像学检查(结肠镜检查、CT 结肠造影、柔性乙状结肠镜检查、胶囊内镜检查等)和粪便检查(粪便免疫化学检测
- FIT、愈创木脂粪便潜血检测
最终用户(医院、诊断实验室、癌症研究机构等)
Colorectal Cancer Diagnostics Market: Strategic Insights
-
CAGR (2022 - 2028)8.7% -
Market Size 2022
US$ 10.37 Billion -
Market Size 2028
US$ 17 Billion
Market Dynamics
- 结直肠癌发病率不断上升
- 新产品发布
- 结肠镜检查中的人工智能
- 人们对结直肠癌的认识不断提高
Key Players
- Medtronic Plc
- Illumina Inc
- Clinical Genomics Technologies Pty Ltd
- EDP Biotech Corp
- Epigenomics AG
- F Hoffmann La Roche Ltd
- Quest Diagnostics Inc
- Novigenix SA
- Siemens Healthineers AG
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
- FIT、愈创木脂粪便潜血检测
复合年增长率(2022 - 2028)8.7%- 2022 年市场规模
103.7 亿美元 - 2028 年市场规模
170 亿美元
市场动态
- 结直肠癌发病率不断上升Colorectal Cancer
- 新产品发布
- 结肠镜检查中的人工智能
- 人们对结直肠癌的认识不断提高Colorectal Cancer
关键人物;主力;重要一员
- 美敦力公司
- Illumina公司
- 临床基因组技术有限公司
- EDP 生物科技公司
- 表观基因组学公司
- F. 霍夫曼-罗氏有限公司
- Quest Diagnostics 公司
- 诺维吉尼克斯公司
- 西门子医疗股份公司
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 影像学检查
- 医院
- 诊断实验室
- 癌症研究机构
- 其他的
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
基于模态的洞察
根据方式,结直肠癌诊断市场分为粪便检查和影像检查。2022 年,影像检查部分在结直肠癌诊断市场中占有更大的份额,预计在预测期内将实现更高的复合年增长率。过去几年,影像检查在结直肠癌诊断中的应用不断发展。影像结果有助于监测、诊断、分期、治疗选择和随访安排。影像检查包括观察结肠和直肠的结构是否存在任何异常区域。影像检查使用内窥镜,一种管状仪器,末端带有灯和微型摄像机,插入直肠。这些检查会扫描结肠和直肠内部,以查找任何可能是癌症或息肉的异常区域。这些检查的使用频率低于粪便检查,需要事先做更多的准备,并且与粪便检查不同,存在一些相关风险。影像学检查进一步分为结肠镜检查、CT结肠造影、柔性乙状结肠镜检查、胶囊内镜检查等。
结肠镜检查领域在 2022 年占据了最大的市场份额。然而,预计 CT 结肠造影术在预测期内将以更快的速度增长。CT 结肠造影术有助于对壁畸形进行形态学分析,为术前评估结肠直肠癌的 T 分期提供所需的信息。根据《实体肿瘤疗效评价标准》(RECIST)的指导方针,CT 是评估转移性结肠和直肠肿瘤患者治疗反应的最广泛使用的方式。CT 结肠造影术的共同优点如下:它快速安全,有助于观察整个结肠,并且无需镇静即可进行检查。建议对平均风险的无症状患者每五年进行一次此项检查。
基于最终用户的洞察
根据最终用户,结直肠癌诊断市场分为医院、诊断实验室、癌症研究机构等。医院部门在 2022 年占据最大市场份额,预计在预测期内将实现最高复合年增长率。
结直肠癌诊断市场参与者采用产品发布和扩张等有机策略来扩大其地理覆盖范围和产品组合并满足不断增长的需求。市场参与者采用的无机增长策略使他们能够扩大业务并增强其地理影响力。此外,这些增长策略有助于公司加强客户群并扩大产品组合。
- 2022 年 12 月,Epigenomics 授权使用蛋白质生物标志物技术进行血液结直肠癌检测。该公司已从德克萨斯大学 MD 安德森癌症中心获得了 与结直肠癌检测相关的生物标志物的某些专利和技术权利。
- 2021 年 8 月,Illumina 收购 GRAIL,以加速患者获得挽救生命的多癌种早期检测测试。GRAIL 的 Galleri 血液检测可在 50 种不同的癌症出现症状之前检测出它们。Illumina 收购 GRAIL 将加速全球范围内获得和采用这种挽救生命的测试。
结直肠癌诊断市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 103.7亿美元 |
2028 年市场规模 | 170亿美元 |
全球复合年增长率(2022 - 2028) | 8.7% |
历史数据 | 2020-2021 |
预测期 | 2023-2028 |
涵盖的领域 | 按方式
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
公司简介
- 美敦力公司
- Illumina公司
- 临床基因组技术有限公司
- EDP 生物科技公司
- 表观基因组学公司
- F. 霍夫曼-罗氏有限公司
- Quest Diagnostics 公司
- 诺维吉尼克斯公司
- 西门子医疗股份公司
- 布鲁克公司
- 荣研化学有限公司
Colorectal Cancer Diagnostics Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ 10.37 Billion |
Market Size by | US$ 17 Billion |
Global CAGR | 8.7% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 检查方式(影像学检查(结肠镜检查、CT 结肠造影、柔性乙状结肠镜检查、胶囊内镜检查等)和粪便检查(粪便免疫化学检测
|
Regions and Countries Covered |
北美(美国、加拿大、墨西哥)
|
Market leaders and key company profiles |
|
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Colorectal cancer diagnostics refers to the tools, kits and test performed on an individual to diagnose colorectal cancer in an individual. This involves series of non-invasive and invasive test to confirm the cancer and its stage based on that treatment will be provided to the patient.
Asia Pacific is expected to be the fastest growing region in the colorectal cancer diagnostics market. Asia Pacific registered as the fastest-growing region in the global colorectal cancer diagnostics market. The market in this region is driven due to rising incidences of colorectal cancer, easy access to the diagnosis for colorectal cancer, and proposing guidelines for the procedures. Also, increasing government funding for research activities in colorectal cancer is expected to propel the growth of the market for colorectal cancer diagnostics in Asia Pacific.
The colorectal cancer diagnostics market, based on modality, is bifurcated into imaging tests and stool based tests. In 2022, the imaging tests segment held the larger share and is expected to grow at a CAGR of 8.8% during the forecast period. Screening and imaging play a vital role in the diagnostics of colorectal cancer to understand the extent of tumor-affected area, that act as a major driving factor for the growth of the imaging tests segment.
The factors that are driving growth of the market are increasing prevalence of colorectal cancer and launches of new products.
The US holds the largest market share in colorectal cancer diagnostics market. The growth of the market in the country is because in 2022, more than 600,000 surgeries are performed annually in the US to treat colon diseases. According to the American Cancer Society, the 5-year survival rate for localized colon cancer is 91% and for localized rectal cancer is 90%.
The colorectal cancer diagnostics market majorly consists of the players such as Medtronic Plc, Illumina Inc, Clinical Genomics Technologies Pty Ltd, EDP Biotech Corp, Epigenomics AG, F Hoffmann-La Roche Ltd, Quest Diagnostics Inc, Novigenix SA, Siemens Healthineers AG, Bruker Corp, and Eiken Chemical Co Ltd.
The List of Companies - Colorectal Cancer Diagnostics Market
- Medtronic Plc
- Illumina Inc
- Clinical Genomics Technologies Pty Ltd
- EDP Biotech Corp
- Epigenomics AG
- F. Hoffmann-La Roche Ltd
- Quest Diagnostics Inc
- Novigenix SA
- Siemens Healthineers AG
- Bruker Corp
- Eiken Chemical Co., Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.